Insider Trading Alert - WDC, REGN And POWI Traded By Insiders

Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Link.

Yesterday, Feb. 25, 2014, 122 U.S. common stocks issued filings of shares being bought or sold by insiders. The transactions ranged in value from $95.53 to $95,971,341.22.

Highlighted Stocks Traded by Insiders:

Western Digital Corporation (WDC) - FREE Research Report

Cordano Michael D who is President, HGST Subsidiary at Western Digital Corporation sold 2,860 shares at $86.57 on Feb. 25, 2014. Following this transaction, the President, HGST Subsidiary owned 85,106 shares meaning that the stake was reduced by 3.25% with the 2,860-share transaction.

The shares most recently traded at $88.32, up $1.75, or 1.98% since the insider transaction. Historical insider transactions for Western Digital Corporation go as follows:

  • 4-Week # shares sold: 4,866
  • 12-Week # shares sold: 7,725
  • 24-Week # shares sold: 77,280

The average volume for Western Digital Corporation has been 2.2 million shares per day over the past 30 days. Western Digital Corporation has a market cap of $20.9 billion and is part of the technology sector and computer hardware industry. Shares are up 4.64% year-to-date as of the close of trading on Tuesday.

Western Digital Corporation, through its subsidiaries, develops, manufactures, and sells storage products and solutions that enable people to create, manage, experience, and preserve digital content. The stock currently has a dividend yield of 1.35%. The company has a P/E ratio of 20.3. Currently there are 11 analysts that rate Western Digital Corporation a buy, 1 analyst rates it a sell, and 4 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on WDC - FREE

TheStreet Quant Ratings rates Western Digital Corporation as a buy. The company's strengths can be seen in multiple areas, such as its increase in net income, revenue growth, largely solid financial position with reasonable debt levels by most measures, expanding profit margins and solid stock price performance. We feel these strengths outweigh the fact that the company has had somewhat disappointing return on equity. Get the full Western Digital Corporation Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

Regeneron Pharmaceuticals (REGN) - FREE Research Report

Goldstein Joseph L who is Director at Regeneron Pharmaceuticals sold 1,000 shares at $338.86 on Feb. 25, 2014. Following this transaction, the Director owned 0 shares meaning that the stake was reduced by 100% with the 1,000-share transaction.

The shares most recently traded at $339.11, up $0.25, or 0.07% since the insider transaction. Historical insider transactions for Regeneron Pharmaceuticals go as follows:

  • 4-Week # shares sold: 2,000
  • 12-Week # shares sold: 15,000
  • 24-Week # shares sold: 20,000

The average volume for Regeneron Pharmaceuticals has been 934,700 shares per day over the past 30 days. Regeneron Pharmaceuticals has a market cap of $34.0 billion and is part of the health care sector and drugs industry. Shares are up 23.48% year-to-date as of the close of trading on Tuesday.

Regeneron Pharmaceuticals, Inc., a biopharmaceutical company, discovers, invents, develops, manufactures, and commercializes medicines for the treatment of serious medical conditions in the United States and internationally. The company has a P/E ratio of 91.2. Currently there are 9 analysts that rate Regeneron Pharmaceuticals a buy, no analysts rate it a sell, and 6 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on REGN - FREE

TheStreet Quant Ratings rates Regeneron Pharmaceuticals as a hold. The company's strengths can be seen in multiple areas, such as its robust revenue growth, largely solid financial position with reasonable debt levels by most measures and good cash flow from operations. However, as a counter to these strengths, we also find weaknesses including deteriorating net income and feeble growth in the company's earnings per share. Get the full Regeneron Pharmaceuticals Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

Power Integrations (POWI) - FREE Research Report

Nayyar Sandeep who is Chief Financial Officer at Power Integrations sold 3,611 shares at $60.25 on Feb. 25, 2014. Following this transaction, the Chief Financial Officer owned 29,407 shares meaning that the stake was reduced by 10.94% with the 3,611-share transaction.

The shares most recently traded at $59.65, down $0.60, or 1.01% since the insider transaction. Historical insider transactions for Power Integrations go as follows:

  • 4-Week # shares sold: 39,913
  • 12-Week # shares sold: 51,887
  • 24-Week # shares sold: 57,989

The average volume for Power Integrations has been 230,000 shares per day over the past 30 days. Power Integrations has a market cap of $1.8 billion and is part of the technology sector and electronics industry. Shares are up 6.75% year-to-date as of the close of trading on Tuesday.

Power Integrations, Inc. designs, develops, manufactures, and markets analog and mixed-signal integrated circuits (ICs), and other electronic components and circuitry used in high-voltage power conversion. The stock currently has a dividend yield of 0.67%. The company has a P/E ratio of 31.7. Currently there are 4 analysts that rate Power Integrations a buy, no analysts rate it a sell, and 3 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on POWI - FREE

TheStreet Quant Ratings rates Power Integrations as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, largely solid financial position with reasonable debt levels by most measures, solid stock price performance, impressive record of earnings per share growth and compelling growth in net income. We feel these strengths outweigh the fact that the company is trading at a premium valuation based on our review of its current price compared to such things as earnings and book value. Get the full Power Integrations Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

null

More from Markets

Jim Cramer: Schlumberger Predicted the Rise in Oil Prices

Jim Cramer: Schlumberger Predicted the Rise in Oil Prices

Jim Cramer on Zillow's New Business: Buying and Selling Homes

Jim Cramer on Zillow's New Business: Buying and Selling Homes

Jim Cramer on the Markets: It's Natural to Have Some Profit Taking

Jim Cramer on the Markets: It's Natural to Have Some Profit Taking

Video: As Trade Worries Subside, Expect a 'Relief Rally' in Stocks

Video: As Trade Worries Subside, Expect a 'Relief Rally' in Stocks

Stocks Trade Mixed Amid Progress on U.S.-China Trade; Dow Turns Lower

Stocks Trade Mixed Amid Progress on U.S.-China Trade; Dow Turns Lower